BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29908438)

  • 21. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
    Yu H; Gou S; Wang Z; Chen F; Fang L
    Eur J Med Chem; 2016 May; 114():141-52. PubMed ID: 26974381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platinum(IV) prodrugs multiply targeting genomic DNA, histone deacetylases and PARP-1.
    Xu Z; Hu W; Wang Z; Gou S
    Eur J Med Chem; 2017 Dec; 141():211-220. PubMed ID: 29031068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformation and recognition of DNA damaged by antitumor cis-dichlorido platinum(II) complex of CDK inhibitor bohemine.
    Novakova O; Liskova B; Vystrcilova J; Suchankova T; Vrana O; Starha P; Travnicek Z; Brabec V
    Eur J Med Chem; 2014 May; 78():54-64. PubMed ID: 24675180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monofunctional platinum-DNA adducts are strong inhibitors of transcription and substrates for nucleotide excision repair in live mammalian cells.
    Zhu G; Myint M; Ang WH; Song L; Lippard SJ
    Cancer Res; 2012 Feb; 72(3):790-800. PubMed ID: 22180496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maximizing Synergistic Activity When Combining RNAi and Platinum-Based Anticancer Agents.
    Xiao H; Qi R; Li T; Awuah SG; Zheng Y; Wei W; Kang X; Song H; Wang Y; Yu Y; Bird MA; Jing X; Yaffe MB; Birrer MJ; Ghoroghchian PP
    J Am Chem Soc; 2017 Mar; 139(8):3033-3044. PubMed ID: 28166401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual-targeting antitumor conjugates derived from platinum(IV) prodrugs and microtubule inhibitor CA-4 significantly exhibited potent ability to overcome cisplatin resistance.
    Huang X; Wang M; Wang C; Hu W; You Q; Yang Y; Yu C; Liao Z; Gou S; Wang H
    Bioorg Chem; 2019 Nov; 92():103236. PubMed ID: 31494328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptide-Coated Platinum Nanoparticles with Selective Toxicity against Liver Cancer Cells.
    Shoshan MS; Vonderach T; Hattendorf B; Wennemers H
    Angew Chem Int Ed Engl; 2019 Apr; 58(15):4901-4905. PubMed ID: 30561882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N'-di-2-propanoic Acid.
    Zmejkovski BB; Pantelić N; Filipović L; Aranđelović S; Radulović S; Sabo TJ; Kaluđerović GN
    Anticancer Agents Med Chem; 2017; 17(8):1136-1143. PubMed ID: 27928952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of novel alkyl pyridine platinum complexes on apoptosis in Ishikawa endometrial cancer cells.
    Czarnomysy R; Bielawska A; Muszyńska A; Bielawski K
    Med Chem; 2015; 11(6):540-50. PubMed ID: 25659127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Antitumor Platinum(II) Conjugates Containing the Nonsteroidal Anti-inflammatory Agent Diclofenac: Synthesis and Dual Mechanisms of Antiproliferative Effects.
    Intini FP; Zajac J; Novohradsky V; Saltarella T; Pacifico C; Brabec V; Natile G; Kasparkova J
    Inorg Chem; 2017 Feb; 56(3):1483-1497. PubMed ID: 28102676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on antitumor mechanism of two planar platinum(II) complexes with 8-hydroxyquinoline: synthesis, characterization, cytotoxicity, cell cycle and apoptosis.
    Qin QP; Chen ZF; Qin JL; He XJ; Li YL; Liu YC; Huang KB; Liang H
    Eur J Med Chem; 2015 Mar; 92():302-13. PubMed ID: 25575314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conjugation of platinum(IV) complexes with chlorambucil to overcome cisplatin resistance via a "joint action" mode toward DNA.
    Qin X; Fang L; Chen F; Gou S
    Eur J Med Chem; 2017 Sep; 137():167-175. PubMed ID: 28586717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative DNA double strand breaks and autophagy in the antitumor effect of sterically hindered platinum(II) complexes in NSCLCs.
    Chen F; Wang X; Jin X; Zhao J; Gou S
    Oncotarget; 2017 May; 8(19):30933-30955. PubMed ID: 28427237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach.
    Musso L; Mazzini S; Rossini A; Castagnoli L; Scaglioni L; Artali R; Di Nicola M; Zunino F; Dallavalle S
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):615-629. PubMed ID: 29229300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondria-targeted platinum(II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells.
    Wang FY; Tang XM; Wang X; Huang KB; Feng HW; Chen ZF; Liu YN; Liang H
    Eur J Med Chem; 2018 Jul; 155():639-650. PubMed ID: 29935437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation.
    Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Yang B; Koppireddi S; Lin Y; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2018 Jan; 143():1039-1052. PubMed ID: 29232581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and Cytotoxic Study of a Platinum(IV) Anticancer Prodrug with Selectivity toward Luteinizing Hormone-Releasing Hormone (LHRH) Receptor-Positive Cancer Cells.
    Yao H; Xu Z; Li C; Tse MK; Tong Z; Zhu G
    Inorg Chem; 2019 Aug; 58(16):11076-11084. PubMed ID: 31393117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, spectroscopic and biological studies of a fluorescent Pt(II) (terpy) based 1,8-naphthalimide conjugate as a DNA targeting agent.
    Banerjee S; Kitchen JA; Bright SA; O'Brien JE; Williams DC; Kelly JM; Gunnlaugsson T
    Chem Commun (Camb); 2013 Oct; 49(76):8522-4. PubMed ID: 23942760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A trifunctional Pt(II) complex alleviates the NHEJ/HR-related DSBs repairs to evade cisplatin-resistance in NSCLC.
    Wang X; Wang Y; Gou S; Chen F
    Bioorg Chem; 2020 Nov; 104():104210. PubMed ID: 32920356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromatin folding and DNA replication inhibition mediated by a highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.
    Imai R; Komeda S; Shimura M; Tamura S; Matsuyama S; Nishimura K; Rogge R; Matsunaga A; Hiratani I; Takata H; Uemura M; Iida Y; Yoshikawa Y; Hansen JC; Yamauchi K; Kanemaki MT; Maeshima K
    Sci Rep; 2016 Apr; 6():24712. PubMed ID: 27094881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.